Esperion Therapeutics Inc... (ESPR)
NASDAQ: ESPR
· Real-Time Price · USD
2.10
0.05 (2.44%)
At close: Aug 18, 2025, 3:59 PM
2.11
0.72%
Pre-market: Aug 19, 2025, 07:00 AM EDT
2.44% (1D)
| Bid | 2.1 |
| Market Cap | 419.42M |
| Revenue (ttm) | 268.13M |
| Net Income (ttm) | -96.09M |
| EPS (ttm) | -0.54 |
| PE Ratio (ttm) | -3.88 |
| Forward PE | -187 |
| Analyst | Buy |
| Ask | 2.15 |
| Volume | 4,299,182 |
| Avg. Volume (20D) | 4,641,135 |
| Open | 2.05 |
| Previous Close | 2.05 |
| Day's Range | 2.01 - 2.11 |
| 52-Week Range | 0.69 - 3.94 |
| Beta | 0.82 |
About ESPR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ESPR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ESPR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Esperion Therapeutics Inc. is scheduled to release its earnings on
Nov 6, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+8.72%
Esperion Therapeutics shares are trading higher af...
Unlock content with
Pro Subscription
5 months ago
+12.03%
Esperion Therapeutics shares are trading higher after the company reported better than expected Q4 FY24 earnings.
